Equflow BV was founded in the 1990s, marking the beginning of our journey with the development of the first turbine flow sensor. About twenty years later, we made a significant leap into the biopharmaceutical market by creating a single-use version that meets all industry requirements. This innovation opened new doors for us, leading to substantial growth and culminating in the acquisition by Saint-Gobain Life Sciences in September 2021. This acquisition has provided numerous opportunities to leverage Equflow’s fluid measurement technologies across all of Saint-Gobain's Life Sciences businesses, particularly enhancing our capabilities in the single-use space for bioprocess solutions.

Equflow is a leading brand under Saint-Gobain Sensors, specializing in the development and production of high-quality single-use flow meters and corresponding equipment. Our sensors are predominantly used in biopharmaceutical and medical processes, such as vaccine manufacturing, cell therapy, and kidney dialysis machines.

At Equflow, we pride ourselves on our global footprint, which uniquely positions us as a leader in single-use solutions. We combine precision, reproducibility, and an excellent price-performance ratio to deliver top-notch products. By collaborating closely with our partners, we tailor custom solutions to meet the specific needs of our valued customers. Our mission is clear: to provide optimal, high-quality solutions for single-use flow measurement, empowering our customers with complete process control at the point of flow measurement. Our comprehensive flow measurement solutions span across all Life Sciences and industrial markets worldwide.